Navigation Links
Robbins & Myers Announces Regular Quarterly Cash Dividend
Date:10/1/2009

DAYTON, Ohio, Oct. 1 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) announced today that its Board of Directors approved a regular cash dividend payment of $0.040 per share. The dividend is payable on November 13, 2009 to shareholders of record as of October 16, 2009.

Robbins & Myers, Inc. is a leading supplier of engineered equipment and systems for critical applications in global energy, industrial, chemical and pharmaceutical markets.

SOURCE Robbins & Myers, Inc.


'/>"/>
SOURCE Robbins & Myers, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
2. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
3. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
4. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
5. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
6. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... SAN DIEGO , March 4, 2015 Aethlon ... devices to address infectious diseases and cancer, today announced ... is scheduled to present a corporate overview at the ... The Ritz-Carlton Hotel in Laguna Niguel, California ... click here ( http://www.roth.com/main/page.aspx?PageID=7207 ). A live ...
(Date:3/4/2015)...   HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... Godshall is scheduled to present at the 2015 ... on Tuesday, March 10, 2015.  The conference is being ... in Florida . A ...
(Date:3/4/2015)... ALPHARETTA, Ga., March 4, 2015  Halyard Health, Inc. ... results and provided its 2015 outlook and related key ... for Halyard Health as we report our fourth quarter ... Abernathy, Chairman and CEO. "We executed a smooth separation ... following the spin-off. We delivered sales growth and margin ...
Breaking Medicine Technology:Aethlon Medical to Present at the 27th Annual ROTH Conference 2HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31
... Essence Orthopaedics, Inc., a medical device company focused on ... has introduced their novel, surgeon-designed PONTiS™ Knotless Endotendonous Repair ... Society for Surgery of the Hand (ASSH). ... upper and lower extremity markets, Core Essence Orthopaedics developed ...
... Optimer Pharmaceuticals (NASDAQ: OPTR ) today ... DIFICID™ (fidaxomicin) tablets will be presented at the 2011 ... place September 17-20 in Chicago. DIFICID was approved by ... of 2011 for the treatment of Clostridium difficile ...
Cached Medicine Technology:Core Essence Orthopaedics Unveiled New Flexor Tendon Repair System at ASSH 2011 2Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC 2Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC 3Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC 4Optimer Pharmaceuticals' DIFICID Featured in 11 Presentations at 51st ICAAC 5
(Date:3/4/2015)... Rafael, CA (PRWEB) March 04, 2015 ... camp directors and staff whose mission is to stimulate ... environment. , “Nike Swim Camps provide campers the opportunity ... in the nation,” says Paul Merrion, Vice President of ... camp experience, enabling each swimmer to build confidence and ...
(Date:3/4/2015)... Follow us on LinkedIn – ... increasing incidence of CNS disorders, aging population, rising healthcare ... The unmet medical needs for diagnosing and treating CNS ... market. Presently, there exists an urgent need for developing ... current generation drugs. Companies are therefore investing to develop ...
(Date:3/4/2015)... March 04, 2015 Nitrosigine®, a patented ... in premium sports nutrition products, is hosting the Nitrosigine ... in the Terrace Ballroom at The Arnold Sports Festival ... 5, 2015 to March 8, 2015. , Nitrosigine ... FDA New Dietary Ingredient notification status; now affirmed as ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... chemical preparations for enhancing the appearance of the skin ... a wide variety of therapeutic agents to achieve the ... products in a society obsessed with physical beauty, youth, ... on the production and sales of cosmetics. Growth in ...
(Date:3/4/2015)... 04, 2015 The report “Vasculitis – ... therapeutic development for Vasculitis. Vasculitis is a disease that ... of vasculitis diseases is not known. Vasculitis can affect ... of symptoms. Symptoms can include fever, weight loss, tiredness, ... pulse in a limb. Vasculitis is treatable, but it ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4
... are seeing the first signs of a reverse brain ... grow over time. The emergence of modern,corporate and investorowned ... NRI doctors back to home turf. ,And unlike other ... the main draw, doctors are actually taking pay cuts ...
... together will build the worlds first "all digital ... by the out patient surgical rehabilitation chain. The ... screens connected to the Internet, electronic medical records ... permitting doctors and other caregivers to access patients' ...
... in the United States of America, says that children suffer ... an unhappy marriage and avoid a divorce for the sake ... only do more damage to the kids, the authors of ... of Pennsylvania State University in University Park conducted the exhaustive ...
... giants has just begun. After waging wars over many drug ... treatment. The ball was set in motion by the dramatic ... AIDS treatment would cost less than a U.S. dollar a ... announced plans of its own production of anti retroviral drugs ...
... humour. It stirred up a controversy. Now it is being ... officially announced that the advertisement in question might not be ... they did not enjoy the advertisement poking fun at organ ... a carousel horse. A team of medics approaches him and ...
... the tedious process of finding survivors of the Gujarat quake, from ... more survivors. They are now concentrating in clearing the rubble and ... far. A miracle baby was saved after nearly 90 hours under ... holding on to the dead body of its mother. The baby ...
Cached Medicine News:Health News:Lure of the home turf brings back NRI doctors 2
Combination Ultrasonic and Pneumatic Urological Lithotriptor. Consists of four sizes of rigid pneumatic probes for use in the kidney, ureter and bladder....
... This therapeutic system is ... patient in mind. As ... and ongoing therapy, SONOCUR ... and effective therapy. Plus, ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
... MODULITH SLX is not only one of the ... versatile medical workstation. Apart from being designed for ... in the urinary tract, the MODULITH SLX can ... endourological therapies. It is equally suitable for the ...
Medicine Products: